Skip to content

A prospective observational study on the evaluation of coagulation function of contrast medium-mixed blood using the blood coagulation analysis device TEG 6s.

A prospective observational study on the evaluation of coagulation function of contrast medium-mixed blood using the blood coagulation analysis device TEG 6s. - Coagulation function evaluation of contrast medium-mixed blood.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052805
Enrollment
100
Registered
2023-12-01
Start date
2023-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients under general anesthesia with an arterial line inserted during surgery.

Interventions

None listed

Sponsors

Tohoku University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Based on the studies that have been conducted, SIH is thought to occur relatively early in life. Some studies have been limited to children, while others have found that the median age of patients was in their 40s. Therefore, the target age for this study will be set at under 60 years old.

Exclusion criteria

Exclusion criteria: Patients with diseases that cause abnormalities in hemostatic coagulation ability, such as protein S/C or antithrombin deficiency, patients whose fibrinogen and platelet values deviate from the reference range in preoperative blood tests, pregnant women, patients who have difficulty obtaining consent forms, and patients who refuse consent.

Design outcomes

Primary

MeasureTime frame
The major evaluation item is to search for the coagulation ability of each specimen by mixing contrast medium and blood collected from patients in the following proportions: 0:1, 1:2, 1:1, 2:1, and 1:0.

Countries

Japan

Contacts

Public ContactHidehisa Saito

Tohoku University Hospital Department of Surgery

hidehisa.saito.e2@tohoku.ac.jp022-717-7321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026